About Michael Ferro
Michael W Ferro, Jr is a healthcare tech entrepreneur and the founder and CEO of Miami based PE Firm Merrick Ventures, focused on democratizing healthcare and artificial intelligence. In his career, Michael has founded and built many companies that went public or were acquired for over $1B.
One of Michael Ferro's exits was after he bought nearly bankrupt Merge Healthcare and built it into a billion-dollar valuation. In 2015, IBM bought Merge Healthcare for $1B. Check out some of the press in Fierce Healthcare, Reuters, ZDNet, and Forbes. Michael Ferro also founded Click Commerce which had an IPO valuation of over $1B.
As part of giving back, Michael founded the Michael and Jacqueline Ferro Foundation, which has donated millions of dollars to many worthy causes. Notable donations include $2M to Northwestern for an entrepreneur incubator and $1M to the Melanoma Research Alliance (MRA). Ferro has won over 15 awards, including the Ernst & Young Technology Entrepreneur of the Year, Forbes Tech’s 100 Highest Rollers, and was a Best Documentary Emmy Award Nominee.
Michael wrote a book with Robin Farmanfarmaian that launched in September of 2022, "How AI Can Democratize Healthcare: The Rise of Digital Care". Check out the Democratizing Healthcare website and the book on Amazon.
About Robin Farmanfarmaian
Robin Farmanfarmaian is a Silicon Valley based professional speaker and entrepreneur working in cutting edge tech poised to impact 100M people or more. Robin has been involved with over 20 early-stage biotech and healthcare startups from curing cancer to medical devices and digital health.
She is an advisor to Luxsonic Technologies, working on a portable and modular radiology reading room in VR. She is also an advisor to Alacrity Care, remote patient monitoring and data analytics for oncology. ConceptVines, a VC fund and product engineering focused on disruptive tech. Robin also donates her time to targeted causes, including co-founding the Organ Preservation Alliance, where she worked with DARPA, the White House and the DoD to fund scientists in cryopreservation and tissue engineering for organ transplants.
With over 180 speaking engagements in 15 countries, she educates audiences on technology, the future of healthcare, artificial intelligence, the shift in healthcare delivery to the patient’s home, and more. Keynote Clients include Boston Scientific, UnitedHealthcare, P&G, Abbott Vascular, Blue Cross Blue Shield NC, Medical Group Management Association (MGMA), American Academy of Dermatologists (AAD), Best Doctors, Virtusa, Verily, AARP, Licensing Executives Society (LES), Medidata, Kaiser Permanente Innovation, American Nurses Association (ANA), Deloitte Life Sciences & Healthcare Network, Frost & Sullivan, Medscape, Dell, Japan Ministry (Tokyo), Rutgers, Stanford, National Association Of Boards Of Pharmacy, CHIME - The College of Healthcare Information Management Executives, and Genentech.
Robin has 4 published books, including: “The Patient as CEO: How Technology Empowers the Healthcare Consumer” and “How AI Can Democratize Healthcare: The Rise of Digital Care” with Michael Ferro.
